Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ISIS Pharmaceuticals, Inc.    ISIS   US4643301090

Delayed Quote. Delayed Nasdaq - 12/19 04:00:06 pm
65.09 USD   +9.30%
1d ago ISIS PHARMACEUT : IWM, HEZU: Big ETF Inflows
4d ago ISIS PHARMACEUT : Initiates Phase 1/2 Study of ISIS-DMPK Rx in Patie..
12/11 ISIS PHARMACEUT : IWM, QAT: Big ETF Inflows
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

ISIS Pharmaceuticals, Inc. : ISIS, YHOO, MU and INTC added to Nasdaq Active Stock Watch List at EPR

06/25/2013 | 09:05am US/Eastern

New York, NY -- (ACCESSWIRE) --06/25/2013-- Equity Profile Report initiates a NASDAQ Active Stock Watch List adding Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), Yahoo! Inc. (NASDAQ:YHOO), Micron Technology Inc. (NASDAQ:MU) and Intel Corporation (NASDAQ:INTC)

Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) a leading company in antisense drug discovery and development finished their previous session (+29.24%) on 9,784,879 shares traded. They recently announced that the data they received from the PHASE 2 study of ISIS-APOCIIIRx in patients with high triglycerides and type 2 diabetes was very positive. They are currently us (+275.93%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Isis Pharmaceuticals, Inc. (NASDAQ:ISIS)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=ISIS&SubId=AW

Yahoo! Inc. (NASDAQ:YHOO) ?a company that provides search, content and communication tools via the web and mobile devices around the world finished their previous session (-4.47%) on 37,007,539. They recently announced that they have completed their acquisition of Tumblr, who are one of the fastest growing media networks in the world. This acquisition is expected to grow Yahoo?s audience by more than one billion monthly visitors. This news has prompted Equity Profile Report to add Yahoo! Inc. (NASDAQ:YHOO) to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Yahoo! Inc. (NASDAQ:YHOO)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=YHOO&SubId=AW

Also mentioned in Equity Profile Report?s Active Stock Watch List and Investor Poll was: Micron Technology Inc. (NASDAQ:MU), Intel Corporation (NASDAQ:INTC), ARM Holdings plc (NASDAQ:ARMH) and NetApp, Inc. (NASDAQ:NTAP)

To see what other investors are saying about: MU, INTC, ARMH and NTAP

Click here: http://www.equityprofilereport.com/PR.aspx?stock=MU-INTC-ARMH-NTAP&SubId=AW

EquityProfileReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals EquityProfileReport.com is often aware of several large investor awareness campaigns being deployed. Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here:http://www.EquityProfileReport.com

Disclosure: EquityProfileReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit EquityProfileReport.com website, for complete risks and disclosures.

Contact Info:

Equity Profile Report
editor@EquityProfileReport.com


© Accesswire 2013
React to this article
Latest news on ISIS PHARMACEUTICALS, INC.
1d ago ISIS PHARMACEUTICALS : IWM, HEZU: Big ETF Inflows
3d ago ISIS PHARMACEUTICALS : Reports Positive Phase 2 Data for ISIS-FXI Rx for the Pre..
4d ago ISIS PHARMACEUTICALS : Initiates Phase 1/2 Study of ISIS-DMPK Rx in Patients Wit..
5d ago ISIS PHARMACEUTICALS : Assigned Patent
12/11 ISIS PHARMACEUTICALS : IWM, QAT: Big ETF Inflows
12/11 ISIS PHARMACEUTICALS : -APOCIII Rx Phase 2 Study in Patients With Familial Chylo..
12/10 ISIS PHARMACEUTICALS : Releases Final Data from Phase 2 Study
12/08 ISIS PHARMACEUTICALS : Assigned Patent
12/07 ISIS PHARMACEUTICALS : Reports Positive Phase 2 Data for ISIS-FXI Rx for the Pre..
12/05 ISIS PHARMACEUTICALS' : CEO, Dr. Stanley Crooke, Receives Prestigious SCRIP Life..
Advertisement
Chart
Duration : Period :
ISIS Pharmaceuticals, Inc. Technical Analysis Chart | ISIS | US4643301090 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF